Skip to main content
VCbacked
Log inGet Started

Dopl Technologies

Seattle, United States

Dopl is a software platform that enables clinicians to perform remote, AI-driven procedures using existing off the shelf hardware.

$1.5M raised
Dec 2024
Pre-Seed
Health CareSoftware

Top Investors

TechstarsPrecursor VenturesSeattle Angel ConferenceFlywheel Investment ConferenceThe Pitch Fund

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Dopl Technologies

How much funding has Dopl Technologies raised?
Dopl Technologies has raised $1.5M in total funding. The most recent round was Pre-Seed. The last funding was announced in December 2024.
Who are Dopl Technologies's investors?
Dopl Technologies's investors include Techstars, Precursor Ventures, Seattle Angel Conference, Flywheel Investment Conference, The Pitch Fund.
Where is Dopl Technologies headquartered?
Dopl Technologies is headquartered in Seattle, United States.
What does Dopl Technologies do?
Dopl is a software platform that enables clinicians to perform remote, AI-driven procedures using existing off the shelf hardware.
What stage is Dopl Technologies at?
Dopl Technologies is at the Pre-Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Dopl Technologies — Funding & Investors." VCBacked, December 20, 2024, https://www.vcbacked.co/company/dopl-technologies. Accessed June 15, 2026.
APA
VCBacked. (2024). Dopl Technologies — Funding & Investors. Retrieved June 15, 2026, from https://www.vcbacked.co/company/dopl-technologies
Wikipedia (cite web)
{{cite web |title=Dopl Technologies — Funding & Investors |url=https://www.vcbacked.co/company/dopl-technologies |website=VCBacked |access-date=June 15, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Health Care

View all
Virtuoso Surgical
Nashville
Basata
Phoenix
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Sedivention
Munich$848K